Connolly Sarah T. - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connolly Sarah T. ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$334,966
+23.6%
53,0010.0%0.23%
+14.6%
Q3 2022$271,000
-18.4%
53,0010.0%0.20%
-11.9%
Q2 2022$332,000
+76.6%
53,0010.0%0.23%
+105.5%
Q1 2022$188,000
-29.3%
53,0010.0%0.11%
-26.2%
Q4 2021$266,000
-31.4%
53,0010.0%0.15%
-53.3%
Q3 2021$388,000
-14.7%
53,0010.0%0.32%
-14.2%
Q2 2021$455,000
-20.7%
53,0010.0%0.37%
-27.1%
Q1 2021$574,000
+9.8%
53,0010.0%0.51%
+6.7%
Q4 2020$523,00053,0010.48%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 54,298$3431.69%
Trium Capital LLP 679,744$4,2961.58%
Vazirani Asset Management LLC 125,000$7901.34%
Atlas Venture Advisors, Inc. 574,996$3,633,9751.25%
Crystalline Management Inc. 375,000$2,370,0001.19%
DAFNA Capital Management LLC 576,881$3,645,8881.03%
BCK CAPITAL MANAGEMENT LP 137,459$868,7410.89%
Atlas Venture Life Science Advisors, LLC 599,524$3,788,9920.46%
Ridgeback Capital Investments L.P. 52,509$331,8570.40%
Connolly Sarah T. 53,001$334,9660.23%
View complete list of F-STAR THERAPEUTICS INC shareholders